Evidence map›Paper›PMID 26311356›Full record

ReviewInfectious disease clinics of North America2015

Prevention of Recurrent Staphylococcal Skin Infections.

C Buddy Creech, Duha N Al-Zubeidi, Stephanie A Fritz

Abstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Advances in methods for rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Clinical Impact ofAntibiotics (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Microbiology spectrum · 2023
    Article
  9. Review
  10. Methicillin ResistantInfection and drug resistance · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Management and Prevention of Staphylococcus aureus Infections in Children.Infectious disease clinics of North America · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Staphylococcus aureus Skin and Soft Tissue Infection Recurrence Rates in Outpatients: A Retrospective Database Study at 3 US Medical Centers.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  20. International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C Buddy CreechVanderbilt Vaccine Research Program, Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine and the Monroe Carell, Jr. Children's Hospital at Vanderbilt, S2323 MCN, 1161 21st Avenue South, Nashville, TN 37232, USA.
Duha N Al-ZubeidiDepartment of Pediatrics, Children's Mercy Hospital Infection Prevention and Control, University of Missouri-Kansas City School of Medicine, 2401 Gillham Road, Kansas City, MO 64108, USA.
Stephanie A FritzDivision of Pediatric Infectious Diseases, Department of Pediatrics, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8116, St Louis, MO 63110, USA. Electronic address: fritz_s@kids.wustl.edu.

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
Washington University Institute of Clinical and Translational Sciences (KL2)KL2RR024994 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$8.6M
EPIDEMIOLOGY AND ERADICATION OF MRSA IN HOUSEHOLDS WITH CHILDRENR01HS021736 · AHRQ · WASHINGTON UNIVERSITY · PI FRITZ, STEPHANIE ANN · 2012 to 2016
$2.5M
Toll-like Receptor 2, Vitamin D, and Extrapulmonary TuberculosisK23AI091692 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FISKE, CHRISTINA A. · 2011 to 2015
$540k
TRANSMISSION DYNAMICS OF CA-MRSA AMONG HOUSEHOLD MEMBERS AND THE HOME ENVIRONMENTK23AI091690 · NIAID · WASHINGTON UNIVERSITY · PI FRITZ, STEPHANIE ANN · 2011 to 2014
$506k
AHRQ HHS R01 HS021736AHRQ HHS R01-HS021736NCATS NIH HHS KL2 TR000450NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1-TR000448NCRR NIH HHS KL2 RR024994NCRR NIH HHS KL2-RR024994NIAID NIH HHS K23 AI091690NIAID NIH HHS K23-AI091690NIAID NIH HHS K23 AI091692
6 · The paper itself

Abstract

Staphylococcus aureus infections pose a significant health burden. The emergence of community-associated methicillin-resistant S aureus has resulted in an epidemic of skin and soft tissue infections (SSTI), and many patients experience recurrent SSTI. As S aureus colonization is associated with subsequent infection, decolonization is recommended for patients with recurrent SSTI or in settings of ongoing transmission. S aureus infections often cluster within households, and asymptomatic carriers serve as reservoirs for transmission; therefore, a household approach to decolonization is more effective than measures performed by individuals alone. Novel strategies for the prevention of recurrent SSTI are needed.

Indexed as

Anti-Bacterial AgentsCarrier StateCommunity-Acquired InfectionsFamily CharacteristicsFemaleHumansMethicillin ResistanceMethicillin-Resistant Staphylococcus aureusRecurrenceRisk FactorsStaphylococcal Skin InfectionsStaphylococcus aureusAnti-Bacterial AgentsDecolonizationMRSAPediatricsPreventionSkin infectionStaphylococcal vaccineStaphylococcus aureus

Identifiers

PMID26311356
PMCPMC4552962

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.